Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial

Journal of Bone and Mineral Research

Volumn 18, Issue 2, 2003, Pages 319-324

  Salmén, Timo ^a   Heikkinen, Anna Mari ^b   Mahonen, Anitta ^a   Kröger, Heikki ^b   Komulainen, Marja ^b   Pallonen, Heli ^a   Saarikoski, Seppo ^b   Honkanen, Risto ^a   Mäenpää, Pekka H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Androgen receptor; Bone; Fracture; Menopause; Polymorphism

Indexed keywords

ANDROGEN RECEPTOR; CALCIUM LACTATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; D CALSOR; ESTRADIOL VALERATE;

ADULT; ALLELE; ARTICLE; BONE MINERAL; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTURE; GENETIC POLYMORPHISM; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENOPAUSAL SYNDROME; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY; TRINUCLEOTIDE REPEAT;

AGED; ALLELES; BONE DENSITY; CHOLECALCIFEROL; CYPROTERONE ACETATE; ESTRADIOL; EXONS; FEMALE; FRACTURES, BONE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RANDOM ALLOCATION; RECEPTORS, ANDROGEN; TIME FACTORS;

EID: 12244313027     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.2.319     Document Type: Article

References (26)

1. Speroff L, Glass RH, Kase NG. 1999 Menopause and the perimenopausal transition. In: Mitchell C (ed) Clinical Gynecologic Endocrinology and Infertility, 6th ed. Lippincott Williams & Wilkins, Baltimore, MD, USA, pp. 656-660.
2. Davis SR, McCloud P, Strauss BJ, Burger H 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21:227-236.
3. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ 1995 Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 85:529-537.
4. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81:37-43.
5. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Yang HM, Nolan J 1999 A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 44:1012-1020.
6. Chamberlain NL, Driver ED, Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186.
7. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL 1997 Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82:3777-3782.
8. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA 2000 Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9:267-274.
9. Duncan EL, Brown MA, Sinsheimer J, Bell J. Carr AJ, Wordsworth BP, Wass JA 1999 Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res 14:1993-1999.
10. Sowers M, Willing M, Burns T, Deschenes S, Hollis B, Crutchfield M, Jannausch M 1999 Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 14:1411-1419.
11. Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landen M, Jansson M, Holm G, Bjorntorp P, Eriksson E 2001 Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562-2568.
12. Tuppurainen M, Honkanen R, Kröger H, Saarikoski S, Alhava E 1993 Osteoporosis risk factors, gynecological history and fractures in perimenopausal women - the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 17:89-100.
13. Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Saarikoski S 1998 HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 31:45-54.
14. Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Jurvelin J, Saarikoski S 1999 Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 84:546-552.
15. 3 - a prospective, controlled, randomized study. J Clin Endocrinol Metab 82:2476-2482.
16. Komulainen M, Tuppurainen MT, Kröger H, Heikkinen A-M. Puntila E, Alhava E, Honkanen R, Saarikoski S 1997 Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized, placebo-controlled study. Osteoporos Int 7:126-132.
17. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R 1992 Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253.
18. Salmén T. Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH 2000 Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy. J Bone Miner Res 15:315-321.
19. Lyon MF 1999 X-chromosome inactivation. Curr Biol 9:R235-R237.
20. Greenspan SL, Neer RM, Ridgway EC, Klibanski A 1986 Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 104:777-782.
21. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr 1987 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intem Med 106:354-361.
22. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A 1996 Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358-4365.
23. Miller KK 2001 Androgen deficiency in women. J Clin Endocrinol Metab 86:2395-2401.
24. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC 1996 Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14-21.
25. Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. J Bone Miner Res 12:1833-1843.
26. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE 1997 The localization of androgen receptors in human bone. J Clin Endocrinol Metab 82:3493-3497.